In 1672, a Dutch anatomist named Regnier de Graaf cut open a rabbit's ovary and found something nobody had described before: small, fluid-filled sacs. He was convinced he'd found the eggs themselves. He hadn't. What he'd actually discovered was the egg's temporary home — the follicle. It would take another 155 years before Estonian naturalist Karl Ernst von Baer finally spotted the real oocyte hiding inside one. De Graaf's name stuck around anyway. To this day, a mature, ovulation-ready follicle is still called a Graafian follicle.
Fast-forward to now, and that little fluid sac is one of the most talked-about structures in reproductive medicine. If you've ever had a fertility scan, tracked ovulation, or read through an IVF protocol, chances are you've run into the term "dominant follicle" more than once. So what exactly is it, how fast does it grow, what do the size measurements actually mean — and why does only one follicle out of dozens get to go all the way?
Every cycle, a cohort of antral follicles — the small, visible-on-ultrasound sacs measuring 2–10 mm — starts growing inside the ovaries. Anywhere from five to fifteen of them enter this race at once. But nature is stingy: only one, in a typical cycle, gets to reach ovulation. That one is the dominant follicle.
The selection process runs on feedback. Early in the cycle, the pituitary gland releases follicle-stimulating hormone, or FSH, which kicks the whole cohort into growth. Whichever follicle happens to be most sensitive to FSH — usually because its granulosa cells carry more receptors than the others — grows faster and starts pumping out more estradiol. Rising estradiol then does something clever: it suppresses further FSH release. The slower follicles, starved of the hormonal fuel they need, stall out and quietly fade away through a process called atresia. The dominant one, meanwhile, has already built up its own receptors for luteinizing hormone (LH), so it keeps growing even as FSH levels drop.
Reproductive biologists sometimes call this the "winner-takes-all" principle. Out of a whole field of candidates, the body picks exactly one — a tidy way to avoid wasting resources on maturing several eggs in the same month.
One question comes up constantly, whether on patient forums or in the exam room: how big should the dominant follicle be on any given day? Here's the average trajectory for a standard 28-day, unstimulated cycle.
| Cycle day | Average follicle size | What's happening |
|---|---|---|
| 5–7 | 4–6 mm | One follicle starts pulling ahead of the antral cohort |
| 8–10 | 10–12 mm | It's now visibly bigger than its neighbours — this is the dominant follicle |
| 11–13 | 14–17 mm | Growth speeds up to roughly 1.5–2 mm a day |
| 14–16 | 18–24 mm | Pre-ovulatory size is reached; ovulation is close |
In a natural cycle, ovulation typically happens once the follicle hits 18–24 mm, averaging around 20–22 mm. If your numbers come in a bit faster or slower than the table above, that's not necessarily a red flag — day-to-day variation of 1 to 3 mm is well within normal range. This is exactly why doctors rarely rely on a single measurement. Follicle tracking, known as folliculometry, is usually done as a series of scans every one to two days, starting around day 8 to 10.
The history of follicle monitoring is tangled up with the history of IVF itself. When Louise Brown — the world's first baby conceived through in vitro fertilization — was born in England in 1978, doctors Patrick Steptoe and Robert Edwards had to lean mostly on hormone bloodwork and laparoscopy to figure out whether an egg was mature. Transvaginal ultrasound, which we take for granted today, didn't become standard clinical practice until the early 1980s. Once it arrived, it quickly became the gold standard for ovulation monitoring, because for the first time, doctors could actually watch the follicle in real time, with no surgery involved.
On a scan, the dominant follicle shows up as a round or slightly oval dark area — fluid doesn't reflect sound waves the way solid tissue does, so it appears black against the lighter ovarian tissue around it. A sonographer identifies it by three things: it's bigger than every other follicle in that ovary, its shape gets rounder and more regular as ovulation approaches, and repeat scans show it consistently growing while the others stall. Right before ovulation, you sometimes see a small bump on the inner wall — the cumulus oophorus, a cluster of cells anchoring the egg in place.
After ovulation, the ruptured follicle transforms into the corpus luteum, a short-lived hormone-producing structure that pumps out progesterone. It shows up on ultrasound too, and a follow-up scan confirming its presence is one way doctors verify that ovulation actually happened.
No — and this distinction matters. A dominant follicle simply means there's a candidate ready for ovulation this cycle, and possibly for fertilization down the line. Everything still has to fall into place after that: an LH surge, follicle rupture, the egg making its way into the fallopian tube, a sperm cell finding it, fertilization, embryo development, and finally implantation in a receptive lining. Any one of those steps can fail to happen. A healthy, well-grown dominant follicle is a good sign, not a guarantee.
That said, tracking it remains one of the most reliable ways to pin down the fertile window — whether you're trying naturally, going through intrauterine insemination, or timing an embryo transfer in a donor-egg cycle.
Sometimes the "one winner" rule gets broken, and two or more follicles reach dominance in the same cycle. In unassisted cycles, this happens naturally in some women — and it's the reason fraternal (dizygotic) twins exist without any fertility treatment at all. It's simply a double ovulation.
In ovulation-stimulation protocols, multiple dominant follicles are often the whole point: during intrauterine insemination, doctors sometimes deliberately aim for two mature follicles to improve the odds. IVF works the other way entirely — gonadotropins are used to stimulate growth in eight to fifteen follicles at once, so as many eggs as possible can be retrieved during the procedure. In that context, "dominant" stops referring to a single follicle and instead describes the whole leading cohort.
Not every dominant follicle makes it to a clean ovulation. Sometimes it keeps growing past the point where it should have ruptured, turning into a functional ovarian cyst — usually harmless and self-resolving within one to three cycles.
A rarer condition is luteinized unruptured follicle syndrome, or LUFS, where the follicle goes through all the hormonal motions of ovulation except the one that matters: the wall never actually ruptures, and the egg stays trapped inside. Bloodwork and ultrasound can look entirely normal, which is part of what makes it tricky to catch. The condition was first described in detail in the late 1970s, once laparoscopy gave doctors direct visual access to the ovary at the moment ovulation was supposed to happen — and it turned out that a seemingly textbook cycle could sometimes hide an ovulation that simply never occurred.
Then there's empty follicle syndrome — rarer still, and well documented since the mid-1980s. During an IVF retrieval, follicles that looked perfectly mature on every scan turn out to contain no retrievable egg at all. The exact cause is still debated; theories range from individual quirks in egg maturation to timing issues with the hCG trigger shot.
People often mix up the dominant follicle with ovarian reserve — the broader measure of how many eggs are left, usually estimated through an antral follicle count or AMH bloodwork. They're related, but they're not interchangeable. Ovarian reserve tells you roughly how many eggs you've got left, sometimes for years to come. The dominant follicle is a single cycle's story: whichever follicle happens to be winning the race this month. A woman can have an excellent ovarian reserve and still run into a sluggish dominant follicle in one particular cycle, or vice versa.
Understanding how the dominant follicle behaves is especially relevant in three situations many MAPASGEN users find themselves in. First, donor-egg cycles: timing between donor and recipient is synchronized almost entirely around follicle-tracking data. Second, IVF protocol decisions: how follicles respond to stimulation directly shapes a doctor's choices around medication doses, the timing of the trigger shot, and the day of egg retrieval. Third, natural conception within co-parenting or partner arrangements: knowing your cycle phase and follicle progress means fewer wasted months and more precisely timed attempts.
It's a remarkable journey when you think about it — from de Graaf's 17th-century mix-up to today's millimeter-precise ultrasound tracking that can predict ovulation almost to the day. Nearly 350 years separate the two. Every time someone looks at a dark circle on a screen during a fertility scan, they're benefiting from generations of scientists and doctors who slowly got it right.
The biology behind the dominant follicle is the same everywhere — but access to the donor and stimulated-cycle programs where that monitoring happens varies enormously by country: who's legally allowed treatment, whether egg donation is even permitted, whether donors stay anonymous, and how much the state pays for. That matters a lot if you're weighing treatment abroad rather than at home.
| Country | Who can be treated | Egg donation | Public funding |
|---|---|---|---|
| Spain | Couples, single women, LGBT+ couples — no restrictions | Legal, anonymous; Europe's largest donor pool | Mostly private |
| France | Couples, single and same-sex women (since 2021) | Legal, anonymous | Up to 4 cycles, under 43, state system |
| United Kingdom | Couples, single women, LGBT+ couples | Legal, donor identity disclosed at 18 | Partial NHS funding, varies by region |
| Germany | Mostly heterosexual couples | Banned by law (1990) | Covers own-egg treatment only |
| Portugal | Couples, single women, lesbian couples | Legal, donor identity disclosed | Limited number of state-funded cycles |
| Denmark | Couples, single women, LGBT+ couples | Legal, anonymous or open by donor's choice | Up to 3 cycles, state system |
| Czech Republic | Heterosexual couples (incl. unmarried) | Legal, anonymous, affordable | Mostly private |
| Israel | One of the highest IVF rates per capita worldwide | Legal, anonymous | State insurance covers a large share of cycles |
| Brazil | Couples, single women, same-sex couples | Governed by professional council, not a single law | Mostly private |
| Greece | Couples, single women, broad access | Legal, anonymous | Mostly private |
| Cyprus | Couples, single women, LGBT+ couples | Legal | Mostly private |
| Ukraine | Broad access, including surrogacy | Legal | Mostly private |
Germany stands out for banning egg donation outright under its 1990 Embryo Protection Act, which is why so many German patients who need a donor egg end up doing their monitoring and stimulation in the Czech Republic or Spain instead. The Czech Republic, for its part, is open to heterosexual couples — married or not — but not to single women, while keeping donation anonymous and treatment costs among the lowest in Europe. Spain remains the continent's largest donor-egg hub and treats patients regardless of relationship status. Denmark, Portugal, and the UK sit among the most inclusive countries for single women and same-sex couples, each offering partial state funding. Israel holds one of the highest IVF-cycle rates per capita anywhere in the world, while Brazil and Ukraine continue to draw patients willing to travel for more accessible treatment.